Form D — Pillar Therapeutics, Inc.
0002133041-26-000001 · filed 2026-05-13
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $25,000,000
- Total sold
- $14,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pillar Therapeutics, Inc.
- CIK
- 2133041
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116 - Phone
- 720-566-4255
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
COSMAS GIALLOURAKISV · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
TESS CAMERON · DirectorBOSTON, MA Find on LinkedIn ↗
-
JENNA HEBERT · DirectorBOSTON, MA Find on LinkedIn ↗
-
AMANDA CREEDON · Executive OfficerBOSTON, MA Find on LinkedIn ↗
View original on SEC EDGAR.